TerrAscend Canada receives EU GMP certification, announces distribution agreement with German partner Will begin distribution in Germany this quarter through agreement with iuvo Therapeutics GmbH, which holds authorization to distribute to pharmacies in the...
read more →
The marijuana industry remains a breeding ground for some of the fastest growing companies, and for those willing to invest in these companies it can be a far from obvious...
read more →
NEW YORK, May 2, 2019 /CNW/ - iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN) (OTCQX: ITHUF), which owns, operates, and partners with best-in-class regulated cannabis operations across the United States,...
read more →
Founded by top global herbal medicine manufacturer Bionorica SE, C3 is a leader in cannabinoid-based medical therapies used by European physicians to treat patients The acquisition brings together Canopy Growth's medical...
read more →
MONTEGO BAY, Jamaica, May 1, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. ("TGOD" or the "Company") (TSX: TGOD) (OTCQX: TGODF) is pleased to announce, in conjunction with Epican Medicinals ("Epican"),...
read more →
Brings together two of the most well-known, fastest growing cannabis brands on the East Coast and West Coast Combines the largest retail operator and the highest revenue generating wholesaler in...
read more →
VANCOUVER, British Columbia, May 01, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH) (OTCQX: EMHTF) today reported financial results for the fourth quarter and year ended December...
read more →
TORONTO, May 01, 2019 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSXV: WMD) (OTCQX: WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report...
read more →
NEW YORK, April 30, 2019 (GLOBE NEWSWIRE) -- Acreage Holdings, Inc. (“Acreage”) (CSE: ACRG.U) (OTC: ACRGF) (FSE: 0ZV) announced it has publicly posted a letter to shareholders from Kevin Murphy,...
read more →
Even before Aleafia Health (TSX: ALEF) (OTCQX: ALEAF) (FRA: ARAH) acquired Emblem it was worth $6.50 according to Mackie Research. It seems that the market is adjusting to the newly-formed...
read more →
« Previous Page — Next Page »
